Compare SNGX & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNGX | FGI |
|---|---|---|
| Founded | 1987 | 1987 |
| Country | United States | United States |
| Employees | N/A | 426 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 16.0M |
| IPO Year | 2006 | 2021 |
| Metric | SNGX | FGI |
|---|---|---|
| Price | $0.37 | $8.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 205.9K | ★ 3.6M |
| Earning Date | 05-08-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.03 | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | ★ $119,371.00 | N/A |
| Revenue This Year | N/A | $6.38 |
| Revenue Next Year | N/A | $6.06 |
| P/E Ratio | ★ N/A | $45.47 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.28 | $3.14 |
| 52 Week High | $2.98 | $19.93 |
| Indicator | SNGX | FGI |
|---|---|---|
| Relative Strength Index (RSI) | 44.18 | 59.56 |
| Support Level | $0.36 | $5.25 |
| Resistance Level | $0.42 | $10.46 |
| Average True Range (ATR) | 0.02 | 0.59 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 19.84 | 69.20 |
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, it generates the majority of its revenue from the United States, followed by Canada and Europe.